- Details
- Description
Strength:
Larotrectinib INN 25 mg
Composition:
Larotrectinib INN 25 mg
Treatment:
NTRK gene fusion-positive solid tumors
Brand:
Laronib 25
Manufacturer:
Everest Pharmaceuticals Ltd.
Laronib 25 is an oral targeted anticancer medicine containing Larotrectinib 25 mg, a selective TRK inhibitor. It is used for the treatment of solid tumors that have an NTRK gene fusion, where the tumor has the specific genetic alteration. Larotrectinib works by blocking TRK signaling involved in cancer-cell growth and survival and is used under specialist medical supervision.
